Total Payments
$11,590
2024 Payments
$2,409
Companies
48
Transactions
461
Medicare Patients
19,346
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$9,184 (79.2%)
Travel$1,796 (15.5%)
Education$610.22 (5.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,184 | 440 | 79.2% |
| Travel and Lodging | $1,796 | 7 | 15.5% |
| Education | $610.22 | 14 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inspire Medical Systems, Inc. | $1,716 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,573 | 108 | $0 (2024) |
| ZOLL Respicardia, Inc. | $1,303 | 8 | $0 (2024) |
| United Therapeutics Corporation | $951.96 | 26 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $948.14 | 40 | $0 (2024) |
| Insmed, Inc. | $623.58 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $573.78 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $459.27 | 27 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $446.69 | 23 | $0 (2024) |
| Grifols USA, LLC | $219.36 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,409 | 95 | United Therapeutics Corporation ($360.97) |
| 2023 | $4,657 | 120 | ZOLL Respicardia, Inc. ($1,273) |
| 2022 | $1,440 | 65 | Actelion Pharmaceuticals US, Inc. ($309.02) |
| 2021 | $766.61 | 29 | Inspire Medical Systems, Inc. ($200.67) |
| 2020 | $294.79 | 18 | Insmed, Inc. ($79.72) |
| 2019 | $516.60 | 33 | GlaxoSmithKline, LLC. ($171.74) |
| 2018 | $601.88 | 44 | GlaxoSmithKline, LLC. ($169.25) |
| 2017 | $903.94 | 57 | GlaxoSmithKline, LLC. ($289.33) |
All Payment Transactions
461 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Immunology | ||||||
| 12/02/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/25/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $11.13 | General |
| Category: Narcoplepsy | ||||||
| 10/28/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $1.08 | General |
| Category: Narcoplepsy | ||||||
| 10/24/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: ANTIBIOTIC | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 4,439 | 5,144 | $1.3M | $333,681 |
| 2022 | 33 | 4,746 | 5,598 | $1.3M | $343,037 |
| 2021 | 35 | 5,241 | 6,216 | $1.5M | $406,647 |
| 2020 | 38 | 4,920 | 5,922 | $1.3M | $339,755 |
Total Patients
19,346
Total Services
22,880
Medicare Billing
$1.4M
Procedure Codes
163
All Medicare Procedures & Services
163 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 215 | 225 | $411,600 | $104,683 | 25.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 154 | 154 | $257,609 | $68,754 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 215 | 348 | $85,260 | $31,839 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 190 | 250 | $43,750 | $15,083 | 34.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 313 | 314 | $36,110 | $12,332 | 34.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 294 | 295 | $44,250 | $12,000 | 27.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,282 | 1,578 | $59,964 | $9,646 | 16.1% |
| 32557 | Drainage of fluid from chest cavity with insertion of indwelling tube using imaging guidance | Facility | 2023 | 51 | 73 | $86,900 | $8,577 | 9.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 140 | $19,890 | $8,564 | 43.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 87 | 92 | $31,395 | $7,974 | 25.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 225 | 225 | $29,700 | $6,371 | 21.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 66 | 68 | $23,205 | $5,690 | 24.5% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 117 | 124 | $16,120 | $5,527 | 34.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 24 | $12,600 | $3,982 | 31.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 37 | $9,435 | $3,746 | 39.7% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 25 | 25 | $33,625 | $3,460 | 10.3% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 40 | 40 | $43,580 | $3,036 | 7.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 141 | 184 | $8,188 | $2,831 | 34.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,245 | $2,601 | 35.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $6,375 | $2,297 | 36.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 105 | 105 | $11,235 | $2,010 | 17.9% |
| 32701 | Delineation of thoracic targets for radiation therapy | Office | 2023 | 11 | 12 | $5,400 | $1,922 | 35.6% |
| G0454 | Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist | Office | 2023 | 260 | 291 | $2,910 | $1,889 | 64.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 56 | 56 | $14,000 | $1,417 | 10.1% |
| 42975 | Evaluation of sleep-disordered breathing by examination of upper airway using an endoscope | Facility | 2023 | 18 | 18 | $3,870 | $1,279 | 33.0% |
About Dr. Malcolm Smith, MD
Dr. Malcolm Smith, MD is a Pulmonary Disease healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174525174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Malcolm Smith, MD has received a total of $11,590 in payments from pharmaceutical and medical device companies, with $2,409 received in 2024. These payments were reported across 461 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($9,184).
As a Medicare-enrolled provider, Smith has provided services to 19,346 Medicare beneficiaries, totaling 22,880 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 163 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Texarkana, TX
- Active Since 08/10/2005
- Last Updated 10/03/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1174525174
Products in Payments
- INSPIRE (Device) $1,516
- remede System (Device) $1,303
- TRELEGY ELLIPTA (Drug) $815.32
- Arikayce (Drug) $607.34
- TYVASO (Drug) $533.45
- OFEV (Drug) $470.00
- UPTRAVI (Drug) $435.99
- OPSUMIT (Drug) $394.25
- ANORO (Drug) $289.20
- WAKIX (Drug) $275.42
- DUPIXENT (Biological) $252.56
- ACTHAR (Biological) $210.33
- Inspire Upper Airway Stimulation System (Device) $200.67
- NUCALA (Biological) $197.54
- GLASSIA (Biological) $195.88
- ORENITRAM (Drug) $191.55
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $184.17
- FASENRA (Biological) $177.06
- Wakix (Drug) $171.27
- BREO (Drug) $163.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Texarkana
Suman Sinha, M.d, M.D
Pulmonary Disease — Payments: $15,760
Pulmonary Disease $15,760
Dr. Carlos Perez, Md, MD
Pulmonary Disease — Payments: $10,138
Pulmonary Disease $10,138
Dr. Khalid Sherani, Md, MD
Pulmonary Disease — Payments: $2,277
Pulmonary Disease $2,277
Dr. Bret Craytor, Md, MD
Pulmonary Disease — Payments: $469.81
Pulmonary Disease $469.81
Mrs. Michelle Dehan, Rn, Acnp, RN, ACNP
Pulmonary Disease
Pulmonary Disease